InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Discover the complete record of transactions filed by MCCANN JOE A., Chairman & CEO. Insider active across 1 company, notably POINT Biopharma Global Inc.. Cumulatively, 5 disclosures have been recorded. Breakdown: 1 buy · 0 sell. Total volume traded: €14k. Activity tracked since 29 November 2022. The latest transaction was filed on 6 November 2023 (Don). Regulator: SEC (Form 4). The full history is free.
5 of 5 declarations
Joe A. McCann is the Chief Executive Officer of POINT Biopharma Global Inc. He leads the company in the biopharmaceutical sector, focusing on the development of targeted treatments for cancer. With extensive experience in the industry, Joe A. McCann is responsible for the overall strategy and operational direction of the company.